Davide Campagna

About Davide Campagna

Davide Campagna, With an exceptional h-index of 24 and a recent h-index of 18 (since 2020), a distinguished researcher at Università degli Studi di Catania, specializes in the field of respiratory medicine, electronic cigarette, osas, diabetes mellitus, internal medicine.

His recent articles reflect a diverse array of research interests and contributions to the field:

Tobacco Smoking or Nicotine Phenotype and Severity of Clinical Presentation at the Emergency Department (SMOPHED): Protocol for a Noninterventional Observational Study

Behavioral Therapy for People With Diabetes Who Smoke: A Scoping Review

Distance follow-up by a remote medical care centre improves adherence to CPAP in patients with obstructive sleep apnoea over the short and long term

Protocol for the “magnitude of cigarette substitution after initiation of e-cigarettes and its impact on biomarkers of exposure and potential harm in dual users”(MAGNIFICAT) study

A multicenter prospective randomized controlled trial investigating the effects of combustion-free nicotine alternatives on cardiovascular risk factors and metabolic parameters …

Varenicline for smoking cessation in individuals who smoke cigarettes and use electronic cigarettes: a double-blind, randomised, placebo-controlled phase 3 trial

Comment on Elsayed et al. 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes—2023. Diabetes …

Low levels of endogenous anabolic androgenic steroids in females with severe asthma taking corticosteroids

Davide Campagna Information

University

Position

Specialist in Internal Medicine Italy

Citations(all)

4443

Citations(since 2020)

1997

Cited By

3398

hIndex(all)

24

hIndex(since 2020)

18

i10Index(all)

31

i10Index(since 2020)

27

Email

University Profile Page

Google Scholar

Davide Campagna Skills & Research Interests

respiratory medicine

electronic cigarette

osas

diabetes mellitus

internal medicine

Top articles of Davide Campagna

Tobacco Smoking or Nicotine Phenotype and Severity of Clinical Presentation at the Emergency Department (SMOPHED): Protocol for a Noninterventional Observational Study

JMIR Research Protocols

2024/4/24

Davide Campagna
Davide Campagna

H-Index: 20

Riccardo Polosa
Riccardo Polosa

H-Index: 44

Behavioral Therapy for People With Diabetes Who Smoke: A Scoping Review

2024/4

Distance follow-up by a remote medical care centre improves adherence to CPAP in patients with obstructive sleep apnoea over the short and long term

Journal of Telemedicine and Telecare

2024/3/27

Davide Campagna
Davide Campagna

H-Index: 20

Protocol for the “magnitude of cigarette substitution after initiation of e-cigarettes and its impact on biomarkers of exposure and potential harm in dual users”(MAGNIFICAT) study

Frontiers in Public Health

2024/3/21

Riccardo Polosa
Riccardo Polosa

H-Index: 44

Davide Campagna
Davide Campagna

H-Index: 20

A multicenter prospective randomized controlled trial investigating the effects of combustion-free nicotine alternatives on cardiovascular risk factors and metabolic parameters …

medRxiv

2023

Varenicline for smoking cessation in individuals who smoke cigarettes and use electronic cigarettes: a double-blind, randomised, placebo-controlled phase 3 trial

Eclinicalmedicine

2023/12/1

Comment on Elsayed et al. 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes—2023. Diabetes …

Diabetes Care

2023/11/1

Davide Campagna
Davide Campagna

H-Index: 20

Low levels of endogenous anabolic androgenic steroids in females with severe asthma taking corticosteroids

ERJ open research

2023/10/1

Relationship between tobacco and nicotine products use and clinical presentation at the Emergency Department: study protocol

2023/7/17

Davide Campagna
Davide Campagna

H-Index: 20

Riccardo Polosa
Riccardo Polosa

H-Index: 44

Varenicline and counseling for vaping cessation: a double-blind, randomized, parallel-group, placebo-controlled trial

BMC medicine

2023/7/5

Correction: Smoking and diabetes: dangerous liaisons and confusing relationships

Diabetology & Metabolic Syndrome

2023/6/2

Smoking habits predict adverse effects after mRNA COVID-19 vaccine: empirical evidence from a pilot study

Public health

2023/6/1

Comparing the effectiveness, tolerability, and acceptability of heated tobacco products and refillable electronic cigarettes for cigarette substitution (CEASEFIRE): Randomized …

JMIR Public Health and Surveillance

2023/4/4

An update on lateral flow immunoassay for the rapid detection of SARS-CoV-2 antibodies

2023

Davide Campagna
Davide Campagna

H-Index: 20

Different death rates between COVID-19 waves among unvaccinated patients: moving beyond lessons learned

Internal and Emergency Medicine

2023/1

Davide Campagna
Davide Campagna

H-Index: 20

Riccardo Polosa
Riccardo Polosa

H-Index: 44

Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study

The Lancet Respiratory Medicine

2023/1/1

A Double-Blind, Randomized, Controlled Phase III Trial Investigating Efficacy and Safety of Varenicline for Vaping Cessation in Adult Users

medRxiv

2022/12/20

Taking for granted conclusions from studies that cannot prove causality of respiratory symptoms and vaping

American Journal of Respiratory and Critical Care Medicine

2022/12/15

Davide Campagna
Davide Campagna

H-Index: 20

Health impact of e-cigarettes and heated tobacco products in chronic obstructive pulmonary disease: current and emerging evidence

2022/11/2

Davide Campagna
Davide Campagna

H-Index: 20

Riccardo Polosa
Riccardo Polosa

H-Index: 44

COVID-19 and emergency departments: need for a validated severity illness score. The history of emerging CovHos score

Internal and Emergency Medicine

2022/10

Davide Campagna
Davide Campagna

H-Index: 20

See List of Professors in Davide Campagna University(Università degli Studi di Catania)